Melatonin reduces mortality from Aleutian disease in mink (Mustela vison).
Aleutian disease (AD) results from a persistent parvoviral infection that results in marked hypergammaglobulinemia and immune complex mediated lesions of the kidney, liver, lungs and, arteries. Melatonin protected both a wild type or demi strain and a demi/dark crossed strain of mink from AD. The biogenic amine also afforded protection against other non-diagnosed diseases naturally found on mink farms when it was available from a subcutaneously-placed reservoir. Some genetic strains of mink apparently differed in the resistance of mink to the virus and in the protective ability of melatonin. The demi strain was the most resistant followed by pastels, mahogany, darks, and those strains with the double recessive Aleutian gene. The protective action of melatonin appeared to result from melatonin's ability to scavenge free radicals, but it could also be due to the induction of antioxidant enzymes or to the modulation of immunity. Melatonin also protected mink against distemper.
Ellis
L C
LC
Department of Biology, Utah State University, Logan 84322-5305, USA.
D000453:Aleutian Mink Disease / Q000401:mortality* / Q000517:prevention & control*; D000818:Animals; D000975:Antioxidants; D004343:Drug Implants; D005260:Female; D016166:Free Radical Scavengers; D008297:Male; D008550:Melatonin / Q000008:administration & dosage*; D008907:Mink; D015996:Survival Rate
D000975:Antioxidants; D004343:Drug Implants; D016166:Free Radical Scavengers; D008550:Melatonin